Trial Profile
A Randomized, Double-blind, Active- and Placebo-controlled, Parallel, Multicenter, Phase II an Exploratory Clinical Trial to Evaluate the Efficacy and Safety NVP-1203 in Patients With Acute Low Back Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs Aceclofenac/eperisone (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Navipharm
- 16 Sep 2019 Status changed from recruiting to completed.
- 20 Aug 2018 Planned End Date changed from 30 Nov 2018 to 28 Feb 2019.
- 20 Aug 2018 Planned primary completion date changed from 31 Jul 2018 to 31 Oct 2018.